Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

NBIXNBIX
Showing 8 of 29 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in NEUROCRINE BIOSCIENCES INC

NORTHERN TRUST CORP holds 1.2M shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $163.7M as of 2026-Q1. The position was increased (+1.8% shares). NBIX represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$163.7M

Current Shares

1.2M

Total Value Change

+$52.1M

Total Shares Change

+432,210

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.2M
+1.8%
$163.7M0.0%$131.14
31
2025-Q4
Increased
1.2M
+31.9%
$173.2M0.0%$140.95
39
2025-Q3
Decreased
925,714
-0.4%
$130M0.0%$140.27
0
2025-Q2
Decreased
929,058
-3.0%
$116.8M0.0%$125.42
0
2025-Q1
Decreased
957,280
-2.5%
$105.9M0.0%$113.16
0
2024-Q4
Increased
981,939
+27.3%
$134M0.0%$137.06
38
2024-Q3
Decreased
771,624
-4.8%
$88.9M0.0%$115.06
0
2024-Q2
Increased
810,620
+13.4%
$111.6M0.0%$137.67
34

Other major holders of NBIX: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used